Literature DB >> 9529094

Decreased antitoxic activities among children with clinical episodes of malaria.

P H Jakobsen1, V McKay, R N'Jie, B O Olaleye, U D'Alessandro, G H Zhang, T A Eggelte, C Koch, B M Greenwood.   

Abstract

Healthy Gambian children, children with clinical Plasmodium falciparum malaria, and children with asymptomatic P. falciparum infections were studied to investigate whether antitoxic activities may contribute to protection against malarial symptoms. Markers of inflammatory reactions, soluble tumor necrosis factor receptor I, and C-reactive protein were found in high concentrations in children with symptomatic P. falciparum malaria compared with levels in children with asymptomatic P. falciparum infections or in healthy children, indicating that inflammatory reactions are induced only in children with clinical symptoms. Concentrations of soluble tumor necrosis factor receptor I and C-reactive protein were associated with levels of parasitemia. We detected antitoxic activities in sera as measured by their capacity to block toxin-induced Limulus amoebocyte lysate (LAL) activation. Symptomatic children had decreased capacity to block induction of LAL activation by P. falciparum exoantigen. The decreased blocking activity was restored in the following dry season, when the children had no clinical malaria. Symptomatic children also had the highest immunoglobulin G (IgG) reactivities to conserved P. falciparum erythrocyte membrane protein 1 and "Pfalhesin" (band #3) peptides, indicating that such IgG antibodies are stimulated by acute disease but are lost rapidly after the disease episode. Half of the children with symptomatic infections had low levels of haptoglobin, suggesting that these children had chronic P. falciparum infections which may have caused symptoms previously. Only a few of the children with asymptomatic P. falciparum infections had high parasite counts, and antitoxic immunity in the absence of antiparasite immunity appears to be rare among children in this community.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9529094      PMCID: PMC108101     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Comparison of two simple methods for determining malaria parasite density.

Authors:  B M Greenwood; J R Armstrong
Journal:  Trans R Soc Trop Med Hyg       Date:  1991 Mar-Apr       Impact factor: 2.184

Review 2.  The malaria vaccine: anti-parasite or anti-disease?

Authors:  J H Playfair; J Taverne; C A Bate; J B de Souza
Journal:  Immunol Today       Date:  1990-01

3.  An ELISA test for detecting chloroquine in urine.

Authors:  F C Shenton; M Bots; A Menon; T A Eggelte; M de Wit; B M Greenwood
Journal:  Trans R Soc Trop Med Hyg       Date:  1988       Impact factor: 2.184

4.  Demonstration of soluble Plasmodium falciparum antigens reactive with Limulus amoebocyte lysate and polymyxin B.

Authors:  P H Jakobsen; L Baek; S Jepsen
Journal:  Parasite Immunol       Date:  1988-11       Impact factor: 2.280

5.  Inhibitory immunoglobulin M antibodies to tumor necrosis factor-inducing toxins in patients with malaria.

Authors:  C A Bate; D Kwiatkowski
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

6.  Plasmodium falciparum varies in its ability to induce tumor necrosis factor.

Authors:  R J Allan; A Rowe; D Kwiatkowski
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

7.  Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria.

Authors:  W McGuire; A V Hill; C E Allsopp; B M Greenwood; D Kwiatkowski
Journal:  Nature       Date:  1994-10-06       Impact factor: 49.962

8.  Phase I study of recombinant tumor necrosis factor in cancer patients.

Authors:  M Blick; S A Sherwin; M Rosenblum; J Gutterman
Journal:  Cancer Res       Date:  1987-06-01       Impact factor: 12.701

9.  Malarial parasites induce TNF production by macrophages.

Authors:  C A Bate; J Taverne; J H Playfair
Journal:  Immunology       Date:  1988-06       Impact factor: 7.397

Review 10.  Malaria: toxins, cytokines and disease.

Authors:  P H Jakobsen; C A Bate; J Taverne; J H Playfair
Journal:  Parasite Immunol       Date:  1995-05       Impact factor: 2.280

View more
  4 in total

Review 1.  C-reactive protein and the biology of disease.

Authors:  Waliza Ansar; Shyamasree Ghosh
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

2.  Five-year tracking of Plasmodium falciparum allele frequencies in a holoendemic area with indistinct seasonal transitions.

Authors:  Hoseah M Akala; Angela O Achieng; Fredrick L Eyase; Dennis W Juma; Luiser Ingasia; Agnes C Cheruiyot; Charles Okello; Duke Omariba; Eunice A Owiti; Catherine Muriuki; Redemptah Yeda; Ben Andagalu; Jacob D Johnson; Edwin Kamau
Journal:  J Multidiscip Healthc       Date:  2014-11-06

3.  C-reactive protein as an early biomarker for malaria infection and monitoring of malaria severity: a meta-analysis.

Authors:  Polrat Wilairatana; Praphassorn Mahannop; Thanita Tussato; I-Mee Hayeedoloh; Rachasak Boonhok; Wiyada Kwanhian Klangbud; Wanida Mala; Kwuntida Uthaisar Kotepui; Manas Kotepui
Journal:  Sci Rep       Date:  2021-11-11       Impact factor: 4.379

4.  Low C-reactive protein levels in a traditional West-African population living in a malaria endemic area.

Authors:  Ulrika K Eriksson; David van Bodegom; Linda May; Anna G C Boef; Rudi G J Westendorp
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.